BRB-002

N/A

Report date: 2025/06/13 11:09:53

Base Information

Drug NameBRB-002
Drug Alias NameBRB-002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Cluster of differentiation 47Signal-regulatory protein alpha modulators
TargetsCluster of differentiation 47Signal-regulatory protein alpha
Therapy Area/IndicationsVasculitisAtherosclerosisCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBitterroot Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesBitterroot Bio Inc
Inactive CompaniesN/A
Active IndicationsVasculitisAtherosclerosisCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A